Takeda Manufacturing Austria AG (batch release of API and solvent, manufacturing, primary packaging of API, secondary packaging of API and solvent, quality control of API)
UkraineAll drugs from this manufacturer
-
It is used for the treatment and prevention of bleeding in patients with hemophilia A (congenital or acquired factor VIII deficiency) and in von Willebrand disease, if treatment with desmopressin alone is ineffective or contraindicated.
Dosage form: powder and solvent for injection solution
Active substance Dosage human blood coagulation factor viii 250 IU von willebrand factor 190 IU ATC: B02BD06
-
The drug is used for the therapy and prevention of bleeding in patients with hemophilia A (congenital or acquired factor VIII deficiency), as well as in von Willebrand disease, if treatment with desmopressin is ineffective or contraindicated.
Dosage form: powder and solvent for injection solution
Active substance Dosage human blood coagulation factor viii 500 IU von willebrand factor 375 IU ATC: B02BD06
-
It is used for the treatment and prevention of bleeding in patients with hemophilia A (due to factor VIII deficiency) and von Willebrand disease (if factor VIII deficiency is present).
Dosage form: powder and solvent for injection solution
Active substance Dosage human blood coagulation factor viii 1000 IU von willebrand factor 750 IU ATC: B02BD06